Truist Securities Maintains Buy on SI-BONE, Lowers Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Samuel Brodovsky maintains a Buy rating on SI-BONE (NASDAQ:SIBN) but lowers the price target from $20 to $18.
August 06, 2024 | 12:11 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Truist Securities maintains a Buy rating on SI-BONE but lowers the price target from $20 to $18, indicating a slightly less optimistic outlook.
The maintained Buy rating suggests continued confidence in SI-BONE's performance, but the lowered price target indicates a slightly less optimistic outlook. This could result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100